| Interactions between Microbiome and DME (MICBIO)
|
| Bacteria: Actinobacteria |
| Bifidobacterium adolescentis (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Serum paraoxonase/lactonase 3 (PON3) and Bifidobacterium adolescentis co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bifidobacterium breve (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Serum paraoxonase/lactonase 3 (PON3) and Bifidobacterium breve co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bifidobacterium longum (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Serum paraoxonase/lactonase 3 (PON3) and Bifidobacterium longum co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [3] |
| Eggerthella lenta (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Serum paraoxonase/lactonase 3 (PON3) and Eggerthella lenta co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bacteria: Bacteroidetes |
| Bacteroides cellulosilyticus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Serum paraoxonase/lactonase 3 (PON3) and Bacteroides cellulosilyticus co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bacteroides dorei (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Serum paraoxonase/lactonase 3 (PON3) and Bacteroides dorei co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bacteroides fragilis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Serum paraoxonase/lactonase 3 (PON3) and Bacteroides fragilis co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bacteroides intestinalis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Serum paraoxonase/lactonase 3 (PON3) and Bacteroides intestinalis co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bacteroides sartorii (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Serum paraoxonase/lactonase 3 (PON3) and Bacteroides sartorii co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bacteroides thetaiotaomicron (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Serum paraoxonase/lactonase 3 (PON3) and Bacteroides thetaiotaomicron co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [3] |
| Bacteroides uniformis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Serum paraoxonase/lactonase 3 (PON3) and Bacteroides uniformis co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bacteroides vulgatus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Serum paraoxonase/lactonase 3 (PON3) and Bacteroides vulgatus co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bacteroides xylanisolvens (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Serum paraoxonase/lactonase 3 (PON3) and Bacteroides xylanisolvens co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Odoribacter splanchnicus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Serum paraoxonase/lactonase 3 (PON3) and Odoribacter splanchnicus co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Parabacteroides distasonis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Serum paraoxonase/lactonase 3 (PON3) and Parabacteroides distasonis co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Parabacteroides johnsonii (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Serum paraoxonase/lactonase 3 (PON3) and Parabacteroides johnsonii co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Parabacteroides merdae (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Serum paraoxonase/lactonase 3 (PON3) and Parabacteroides merdae co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Prevotella copri (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Serum paraoxonase/lactonase 3 (PON3) and Prevotella copri co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bacteria: Firmicutes |
| Clostridium botulinum (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Serum paraoxonase/lactonase 3 (PON3) and Clostridium botulinum co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Clostridium perfringens (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Serum paraoxonase/lactonase 3 (PON3) and Clostridium perfringens co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [3] |
| Enterocloster asparagiformis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Serum paraoxonase/lactonase 3 (PON3) and Enterocloster asparagiformis co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Eubacterium limosum (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Serum paraoxonase/lactonase 3 (PON3) and Eubacterium limosum co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [3] |
| Holdemanella biformis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Serum paraoxonase/lactonase 3 (PON3) and Holdemanella biformis co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bacteria: Fusobacteria |
| Fusobacterium varium (fusobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Serum paraoxonase/lactonase 3 (PON3) and Fusobacterium varium co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [3] |
| Bacteria: Lentisphaerae |
| Victivallis vadensis (PVC bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Serum paraoxonase/lactonase 3 (PON3) and Victivallis vadensis co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
|
|
|
|
|
|